A Study of MET233 in Individuals With Obesity or Overweight

NCT07022977 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity and Overweight

Interventions

BIOLOGICAL: MET233
BIOLOGICAL: Placebo

Sponsor

Metsera, a wholly owned subsidiary of Pfizer